P354: REAL-WORLD ANALYSIS OF THE RISKS OF THROMBOTIC AND BLEEDING EVENTS IN PATIENTS RECEIVING PEGYLATED ASPARAGINASE FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

• Record Type: Journal Article
• Authors: Mautner, B.; Brewer, B.; Mort, J.; Pierce, E.; Ghamsari, F.; Dibenedetto, S.; Morse, E.; Wells, L.; Morris, A.; Allen, C.; Patel, I.; D'Souza, D.; Jackson, C.; Perciavalle, M.; Yelvington, B.; Miller, R.; Abernathy, K.; Walsh, K.; Wolfe, H.; Locke, S.; Reed, D.; Duong, V.; Dholaria, B.; LeBlanc, T.; Shallis, R.; Keng, M.; Horton, B.; El Chaer, F.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 254
• Page End: 255
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000844304.82725.a0
• Languages: English
• ISSNs: 2572-9241